

Drug Class: Aromatase Inhibitor (AI)
Active Substance: Letrozole
Strength: 2.5 mg/tablet
Amount: 100 tablets
Active Life: ~2–4 days
Average Dose: 0.5–2.5 mg every other day
Liver Toxicity: Low
Aromatization Rate: Blocks conversion
Anabolic Rate: None
Androgenic Rate: None
Manufacturer: Dragon Pharma
Femara by Dragon Pharma is a powerful aromatase inhibitor (AI) containing 2.5 mg of Letrozole per tablet. Designed to significantly reduce estrogen levels, this product is essential during anabolic steroid cycles involving aromatizing compounds like testosterone, Dianabol, or Nandrolone. By blocking the aromatase enzyme, Femara helps prevent estrogen-related side effects such as water retention, gynecomastia, and elevated blood pressure.
Letrozole binds reversibly to the aromatase enzyme, which is responsible for converting androgens into estrogens. This suppression can reduce circulating estrogen by up to 98% in clinical settings. Its clinical usage spans from breast cancer treatment to off-label use in male hormone modulation. According to peer-reviewed research, Letrozole has demonstrated high efficacy in managing estrogen-sensitive conditions.
Unlike mild AIs like Arimidex, Letrozole is significantly more potent, making it ideal for users running high-dose or heavily aromatizing steroid cycles. Dragon Pharma ensures pharmaceutical-grade purity, consistency, and bioavailability, making it a trusted choice among experienced athletes seeking complete estrogen suppression.
Due to its strength, Letrozole must be dosed carefully to avoid crashing estrogen levels, which may lead to joint pain, mood swings, and libido issues. Most users begin with 0.5 mg every other day and adjust based on bloodwork or symptoms. Full 2.5 mg doses are typically reserved for emergency control of gynecomastia flare-ups.
Femara can be integrated into cycles with high-aromatization compounds like Dragon Pharma Testo Blend 350 or Dragon Pharma Dianabol 50. During post-cycle therapy (PCT), it is often replaced by SERMs such as Dragon Pharma Clomid or Tamoxifen to encourage testosterone recovery while avoiding estrogen rebound.
Each batch of Dragon Pharma Femara is lab-tested and meets pharmaceutical manufacturing standards. Athletes who demand reliable control over their estrogen levels often choose this Letrozole formulation as part of a broader hormone management strategy.
Letrozole is also used during contest preparation phases to help eliminate subcutaneous water retention, giving competitors a dry and vascular appearance. When paired with compounds like Dragon Pharma Tren/Test 350, it maximizes the cosmetic results of cutting cycles.
Since overuse can crash estrogen levels, regular monitoring is advised. Many advanced users rotate Femara use or implement it only when signs of estrogen dominance arise. This flexibility, paired with the product's strength, makes it ideal for experienced users who can interpret bodily feedback or use lab tests to fine-tune estrogen management.
If you're looking for a pharma-grade aromatase inhibitor that delivers on suppression, Dragon Pharma's Letrozole is one of the best options available on the USA market.
Femara is used to suppress estrogen production during anabolic steroid cycles, helping prevent gynecomastia and water retention.
The typical starting dose is 0.5 mg every other day. Higher doses like 2.5 mg are used only for severe estrogen-related side effects.
Letrozole is not usually used during PCT due to its strong suppression. It's better suited for on-cycle estrogen management.
Side effects can include joint pain, reduced libido, mood swings, and fatigue if estrogen is suppressed too much.
Please log in to write Femara 2.5 mg review.
Drug Class: Aromatase Inhibitor (AI)
Active Substance: Letrozole
Strength: 2.5 mg/tablet
Amount: 50 tablets
Active Life: ~2 days
Average Dose: 0.5–2.5 mg/day
Liver Toxicity: Low
Aromatization Rate: N/A (blocks aromatase)
Anabolic Rate: None
Androgenic Rate: None
Manufacturer: Axiolabs
Drug Class: Aromatase Inhibitor (AI)
Active Substance: Letrozole
Strength: 2.5 mg/tablet
Amount: 50 tablets
Active Life: ~48 hours
Average Dose: 0.25–1.25 mg EOD
Liver Toxicity: Low
Aromatization Rate: N/A (blocks estrogen synthesis)
Anabolic Rate: None
Androgenic Rate: None
Manufacturer: British Dragon
Drug Class: Aromatase Inhibitor
Active Substance: Letrozole
Strength: 2.5 mg/tablet
Amount: 30 tablets
Active Life: ~2 days
Average Dose: 0.5–2.5 mg/day
Liver Toxicity: Low
Aromatization Rate: None
Anabolic Rate: N/A
Androgenic Rate: N/A
Manufacturer: Kalpa Pharmaceuticals
Drug Class: Oral Anabolic Androgenic Steroid (AAS)
Active Substance: Oxandrolone
Strength: 10 mg/tablet
Amount: 100 tablets
Active Life: 8–12 hours
Average Dose: 20–50 mg/day (men), 5–15 mg/day (women)
Liver Toxicity: Mild
Aromatization Rate: None
Anabolic Rate: 322–630
Androgenic Rate: 24
Manufacturer: Dragon Pharma
Laboratory Test: View Result
Drug Class: Anabolic Androgenic Steroid (AAS)
Active Substance: Testosterone Cypionate
Strength: 250 mg/mL
Amount: 10 mL Vial
Active Life: 8–10 Days
Average Dose: 250–750 mg/week
Liver Toxicity: Low
Aromatization Rate: High
Anabolic Rate: 100
Androgenic Rate: 100
Manufacturer: Dragon Pharma
Laboratory Test: View Result